A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Eli Lilly Japan and Nippon Shinyaku sign alliance for pirtobrutinib in Japan, aiming to supply the drug for mantle cell lymphoma and chronic lymphocytic leukemia treatment; partnership focused on promoting proper use of the drug
Published:
March 27, 2024
by Contify Life Science News
|
Charles River partners with Singapore's Yong Loo Lin School of Medicine to develop and manufacture plasmid DNA for engineered stem cell cancer therapy; partnership to use Charles River's CDMO expertise in HQ and GMP-compliant plasmid DNA
Published:
March 26, 2024
by Zack's Commentary
|
Patent Issued for Antibody-drug-conjugate and its use for the treatment of cancer (USPTO 11918656)
Published:
March 26, 2024
by NewsRx Pharma Business Daily
|
MorphoSys receives US antitrust clearance for its proposed acquisition by Novartis, following clearance in Germany and Austria; the total equity value of the acquisition stands at €2.7B
Published:
March 25, 2024
by ENP Newswire
|
FDA sends complete response letters to Regeneron over its BLA for odronextamab in follicular lymphoma and diffuse large B-cell lymphoma; letters cite issues with enrollment status of confirmatory trials
Published:
March 25, 2024
by GlobeNewswire
|
Ask us about our Government & Public Policy market view